Cibus, Inc.
CBUS · Price history
Price at last available close
$1.41
−$0.14 (-9.03%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Cibus, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name.
How they make money
Cibus is an agricultural biotechnology company that generates revenue primarily through trait licensing agreements and research collaborations. The company utilizes its proprietary Rapid Trait Development System (RTDS) to perform gene editing directly in a customer's elite germplasm, operating as an extension of the customer's breeding program to develop and commercialize improved crop traits.
Products & services
Cibus provides gene-editing technology and trait development services, including its proprietary Rapid Trait Development System (RTDS), Trait Machine, and specific crop traits such as the Pod Shatter Reduction (PSR) trait for canola.
Brands & revenue mix
Proprietary trait development platform
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
Period ended 2025-12-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
- Seed companiesSource
Customer concentration
The company has historically disclosed concentration in its initial customer base for its PSR trait in canola, though specific customer names are not disclosed in the 2025 10-K.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Strengths
- Proprietary Rapid Trait Development System (RTDS) technologySource
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Diluted weighted-average shares increased 84.4% year over year.
Compare per-share results with total earnings and inspect the equity footnote. A change in weighted-average shares does not by itself establish the cause, the number of shares issued today, or the economic effect of a split.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
12
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
10
Poor
Financial Strength
2
Business Quality / Moat
0
Management
0
Growth Quality
54
Risk / Durability
11
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
29
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
38/100
Building Historical Record
Model Score 38/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
No strong positive signal is being highlighted from the currently available summary data.
- •Elevated debt risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for CBUS
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can CBUS maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can CBUS fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Does CBUS's balance between cash and debt leave enough flexibility if business conditions weaken?
- •What specifically needs to improve for CBUS to reach sustainable profitability?
- •What future growth or profitability would be needed to justify CBUS's current valuation?
Essential Investment Snapshot
Wall Street Score
12
Opportunity Score
29
Market Cap
$107.8M
P/E Ratio
-1.0
EPS
$-1.65
52-Week High
$4.19
52-Week Low
$1.09
Beta
1.59
Analyst Target
$11.50
Shares Outstanding
45.8M
Total Revenue
$4.3M
Total Debt
$32.7M
Dividend
No current dividend
Liquidation Value / Share
$0.32
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for CBUS
Detected from reported data — verify before acting.Elevated debt risk
Total debt is at least one year of revenue • Interest coverage is below 2x • Free cash flow is negative
Community Sentiment
0 active · 0 total callsNo personal call yet on CBUS.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Proprietary Rapid Trait Development System (RTDS) technology.
Potential downside factors
- −Debt risk (elevated): Total debt is at least one year of revenue.
- −Interest coverage is below 2x.
- −Free cash flow is negative.
- −Dependence on successful commercialization of gene-edited traits.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
12
Sep 14, 2026
Change
Unchanged
Current Score
12
Oct 1, 2026
Category Changes
CBUS score was unchanged.
Projected Score
Projected Score
11
Projected Change
-1.1 points
Preliminary comparable-period financial changes suggest decline of approximately 1.1 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$1.41
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3M | $3.6M | $4.3M | $1.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $2.4M | $5.9M | $6.9M | $395K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $2.0M | -$2.3M | -$2.6M | $1.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $37.4M | $44.2M | $50.4M | $42.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $19.7M | $26.9M | $30.8M | $28.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $55.9M | $65.2M | $74.4M | $320.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$58.9M | -$90.8M | -$241.6M | -$314.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$53.9M | -$67.5M | -$77.0M | -$318.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $18.8M | $35.5M | $34.2M | $18.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$99.6M | -$132.2M | -$282.7M | -$337.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $13K | $29K | $29K | -$4K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$98.2M | -$127.1M | -$251.4M | -$267.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-1.65 | $-2.78 | $-10.83 | $-25.95 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 76.76M | 45.76M | 23.22M | 10.31M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 76.76M | 45.76M | 23.22M | 10.31M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$994000
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.29
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-7.6%
Cash Change
-44.0%
Margin Change
+491.5 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, debt levels, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 6.5%. EPS declined 52.5%. Cash declined 44.0%. Total debt declined 7.6%. Net income margin improved by 491.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
BiotechnologyNews
Cibus and Crystal Crop Protection Team Up to Improve India's Mustard Crop
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates
Cibus Q2 Earnings Call Highlights
Rumor Mill · CBUS
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial